BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 16243225)

  • 1. Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis.
    Armstrong MB; Robertson PL; Castle VP
    Pediatr Neurol; 2005 Nov; 33(5):365-7. PubMed ID: 16243225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
    Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
    Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsoclonus myoclonus syndrome: response to plasmapheresis.
    R SS; Mani PJ
    Indian Pediatr; 2004 May; 41(5):499-502. PubMed ID: 15181303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
    Burke MJ; Cohn SL
    Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Opsoclonus myoclonus ataxia syndrome in Israel].
    Blumkin L; Lerman-Sagie T
    Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.
    Tate ED; Allison TJ; Pranzatelli MR; Verhulst SJ
    J Pediatr Oncol Nurs; 2005; 22(1):8-19. PubMed ID: 15574722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsoclonus myoclonus.
    Scarff JR; Iftikhar B; Tatugade A; Choi J; Lippmann S
    Innov Clin Neurosci; 2011 Dec; 8(12):29-31. PubMed ID: 22247816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
    Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
    Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
    Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
    Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
    Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
    Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.
    Mitchell WG; Brumm VL; Azen CG; Patterson KE; Aller SK; Rodriguez J
    Pediatrics; 2005 Oct; 116(4):901-7. PubMed ID: 16199699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome.
    Yiu VW; Kovithavongs T; McGonigle LF; Ferreira P
    Pediatr Neurol; 2001 Jan; 24(1):72-4. PubMed ID: 11182286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses.
    Wilken B; Baumann M; Bien CG; Hero B; Rostasy K; Hanefeld F
    Eur J Paediatr Neurol; 2008 Jan; 12(1):51-5. PubMed ID: 17625938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsoclonus-myoclonus associated with celiac disease.
    Deconinck N; Scaillon M; Segers V; Groswasser JJ; Dan B
    Pediatr Neurol; 2006 Apr; 34(4):312-4. PubMed ID: 16638509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Opsoclonus-myoclonus syndrome].
    Arroyo HA; Tringler N
    Medicina (B Aires); 2009; 69(1 Pt 1):64-70. PubMed ID: 19240003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.
    Matthay KK; Blaes F; Hero B; Plantaz D; De Alarcon P; Mitchell WG; Pike M; Pistoia V
    Cancer Lett; 2005 Oct; 228(1-2):275-82. PubMed ID: 15922508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of opsoclonus-myoclonus syndrome associated with anti-central nervous system antibody].
    Ushiyama M; Ishida K; Ikeda S; Imai H; Yanagisawa N
    Rinsho Shinkeigaku; 1994 Sep; 34(9):898-902. PubMed ID: 7820964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
    Chang BH; Koch T; Hopkins K; Malempati S
    Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paraneoplastic opsoclonus myoclonus ataxia syndrome].
    Aguilera Albesa S; Botella MP; Salado C; Bosque A; Ocio I; Montiano JI
    An Sist Sanit Navar; 2009; 32(1):91-5. PubMed ID: 19430515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dancing eyes, dancing feet: opsoclonus-myoclonus in an 18-month-old child with neuroblastoma.
    Badaki OB; Schapiro ES
    Pediatr Emerg Care; 2007 Dec; 23(12):885-8. PubMed ID: 18091597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.